日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Integrated multi-omics reveals the ITGB2-IL2RB-NK axis in promoting papillary thyroid carcinoma progression and immune microenvironment crosstalk

整合多组学分析揭示了ITGB2-IL2RB-NK轴在促进乳头状甲状腺癌进展和免疫微环境相互作用中的作用

Xu, Jianxiong; Gao, Chen

A hypomorphic Il2rb mutant mouse model recapitulates and reveals mechanisms of human T cell immune dysregulation in IL-2Rβ deficiency

IL-2Rβ 功能减弱的 Il2rb 突变小鼠模型重现并揭示了 IL-2Rβ 缺乏症中人类 T 细胞免疫失调的机制

Berenice Cabrera-Martinez ,Josselyn E Garcia-Perez ,Ryan M Baxter ,Victor G Lui ,Tusharkanti Ghosh ,Ahmet Eken ,Zander Kostka-Newman ,John Rhey Mhar Garcia ,Jeremy Rahkola ,Rachel L Gessner ,Cullen M Dutmer ,Jared Klarquist ,Eric M Pietras ,Debashis Ghosh ,Sara A Johnson ,Ross M Kedl ,Elena W Y Hsieh

BET inhibitors drive Natural Killer activation in non-small cell lung cancer via BRD4 and SMAD3

BET 抑制剂通过 BRD4 和 SMAD3 促进非小细胞肺癌中的自然杀伤细胞活化

Francesca Reggiani, Giovanna Talarico, Giulia Gobbi, Elisabetta Sauta, Federica Torricelli, Veronica Manicardi, Eleonora Zanetti, Stefania Orecchioni, Paolo Falvo, Simonetta Piana, Filippo Lococo, Massimiliano Paci, Francesco Bertolini, Alessia Ciarrocchi, Valentina Sancisi

Retracted: IL2RB Is a Prognostic Biomarker Associated with Immune Infiltrates in Pan-Cancer

撤稿:IL2RB是与泛癌免疫浸润相关的预后生物标志物

Oncology, Journal Of

Protein Kinase Inhibitor-Mediated Immunoprophylactic and Immunotherapeutic Control of Colon Cancer

蛋白激酶抑制剂介导的结肠癌免疫预防和免疫治疗控制

Silvia Ghione, Cindy Racoeur, Nesrine Mabrouk, Jingxuan Shan, Emma Groetz, Elise Ballot, Caroline Truntzer, Lotfi Chouchane, Frédérique Végran, Catherine Paul, Stéphanie Plenchette, Ali Bettaieb

Upregulated Expression of IL2RB Causes Disorder of Immune Microenvironment in Patients with Kawasaki Disease

IL2RB表达上调导致川崎病患者免疫微环境紊乱

Liao, Yunfei; Ke, Ben; Long, Xiaoyan; Xu, Jianjun; Wu, Yongbing

IL2RB Is a Prognostic Biomarker Associated with Immune Infiltrates in Pan-Cancer

IL2RB是与泛癌免疫浸润相关的预后生物标志物

Li, Guangyao; Wang, Yandong; Cheng, Ya

Nicotine exhausts CD8+ T cells against tumor cells through increasing miR-629-5p to repress IL2RB-mediated granzyme B expression

尼古丁通过增加 miR-629-5p 的表达来抑制 IL2RB 介导的颗粒酶 B 的表达,从而耗竭 CD8+ T 细胞对抗肿瘤细胞的能力。

Chun-Chia Cheng,Hsin-Chi Lin,Ya-Wen Chiang,Jungshan Chang,Zong-Lin Sie,Bi-Ling Yang,Ken-Hong Lim,Cheng-Liang Peng,Ai-Sheng Ho,Yi-Fang Chang

Downregulation of miR-497-5p Improves Sepsis-Induced Acute Lung Injury by Targeting IL2RB.

miR-497-5p 下调通过靶向 IL2RB 改善脓毒症引起的急性肺损伤。

A novel human IL2RB mutation results in T and NK cell-driven immune dysregulation

一种新型的人类IL2RB突变导致T细胞和NK细胞驱动的免疫失调

Isabel Z Fernandez # ,Ryan M Baxter # ,Josselyn E Garcia-Perez ,Elena Vendrame ,Thanmayi Ranganath ,Daniel S Kong ,Karl Lundquist ,Tom Nguyen ,Sidney Ogolla ,Jennifer Black ,Csaba Galambos ,James C Gumbart ,Noor Dawany ,Judith R Kelsen ,Edwin F de Zoeten ,Ralph Quinones ,Hesham Eissa ,Michael R Verneris ,Kathleen E Sullivan ,Rosemary Rochford ,Catherine A Blish ,Ross M Kedl # ,Cullen M Dutmer # ,Elena W Y Hsieh #